Inventor · disambiguated record
Jose R. Conejo-Garcia
Also filed as: CONEJO-GARCIA JOSE · CONEJO-GARCIA JOSE R · CONEJO-GARCIA JOSE-RAMON · CONEJO-GARCIA JÓSE
13 granted patents·15 pending applications·37 citations·filing 2001–2025
88Inventor score
Files withWISTAR INST11H LEE MOFFITT CANCER CT & RES9CONEJO GARCIA JOSE R2BZIK DAVID J1COUKOS GEORGE1
Top patents by PatentIndex Score
28 records- 0193US9868951B2Methods and compositions for enhancing the therapeutic effect of anti-tumor T cellsWISTAR INST·Filed 2015·Granted Jan 16, 2018·11 cites·20 claims
- 0292US9226936B2Methods and compositions for enhancing the therapeutic effect of anti-tumor T cellsWISTAR INST·Filed 2012·Granted Jan 5, 2016·13 cites·14 claims
- 0380US9724393B2Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferationWISTAR INST·Filed 2016·Granted Aug 8, 2017·3 cites·7 claims
- 0480US2025340609A1Methods and compositions for treating cancerWISTAR INST·Filed 2025·Application pending·0 cites
- 0573US12384826B2Methods and compositions for treating cancerWISTAR INST·Filed 2021·Granted Aug 12, 2025·0 cites·21 claims
- 0672US2024165225A1Methods and Compositions for Treating Cancers by Inhibiting Estrogen Signaling in Myeloid-Derived Suppressor CellsWISTAR INST·Filed 2023·Application pending·0 cites
- 0768US11248033B2Methods and compositions for treating cancerWISTAR INST·Filed 2019·Granted Feb 15, 2022·0 cites·20 claims
- 0868US9233137B2Dendritic cell modulation in post-ischemic woundsDE MUINCK EBO D·Filed 2009·Granted Jan 12, 2016·2 cites·26 claims
- 0968US8954131B2Magnetic particle imaging (MPI) system and method for use of iron-based nanoparticles in imaging and diagnosisWEAVER JOHN B·Filed 2010·Granted Feb 10, 2015·8 cites·20 claims
- 1065US10351851B2Methods and compositions for enhancing the therapeutic effect of anti-tumor T cellsWISTAR INST·Filed 2017·Granted Jul 16, 2019·0 cites·8 claims
- 1164US2025282853A1Utilization of immortalized b cells to identify sdcbp as a novel therapeutic target in ovarian carcinomaH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1263US2025230260A1Cdrs for glycosylated acat1H LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1363US2025122308A1Targeting mutant kras with a mutation specific igaH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1461US2025179184A1Foxp1-ablated chimeric cellsH LEE MOFFITT CANCER CT & RES·Filed 2025·Application pending·0 cites
- 1558US10259855B2Methods and compositions for treating cancerWISTAR INST·Filed 2015·Granted Apr 16, 2019·0 cites·18 claims
- 1658US2025313622A1Chimeric antigen receptor (car) constructs with nk receptor signaling domainH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1758US2022031747A1Foxp1-ablated chimeric cellsH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 1857US2025339524A1Combination anti-4-1bb immunotherapy, radiotherapy, and b cell activation therapyH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1956US10258625B2Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferationWISTAR INST·Filed 2017·Granted Apr 16, 2019·0 cites·18 claims
- 2056US2019201526A1Methods and Compositions for Treating Cancers by Inhibiting Estrogen Signaling in Myeloid-Derived Suppressor CellsWISTAR INST·Filed 2017·Application pending·0 cites
- 2154US2023416359A1Olfactory receptors for use as targets for antigen binding molecules to detect and treat cancerH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 2253US12479908B2Antibodies against programmed cell death protein 1 (PD1) and uses thereofH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
- 2352US2009124541A1Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseasesIPF PHARMACEUTICALS GMBH·Filed 2007·Application pending·0 cites
- 2448US9757440B2Method for treating cancer with Toxoplasma gondii vaccineBZIK DAVID J·Filed 2011·Granted Sep 12, 2017·0 cites·2 claims
- 2544US2004116652A1Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseasesFiled 2001·Application pending·0 cites
- 2643US2021388089A1Antigen binding agents that bind cd277 and uses thereofCONEJO GARCIA JOSE R·Filed 2019·Application pending·0 cites
- 2743US2006247420A1Immune cell recptor ligand and immune cell receptorCOUKOS GEORGE·Filed 2003·Application pending·0 cites
- 2832US8084217B2CD161 ligand, pilar, for modulating activation and proliferation of T cellsCONEJO-GARCIA JOSE R·Filed 2008·Granted Dec 27, 2011·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →